Articles

Results from two Phase 3 Trials, demonstrate the effectiveness of this new rapid –acting insulin

Type 2 diabetes patients taking sitagliptin (Januvia) for two years don’t seem to have any extra cardiovascular risk from the agent, according to a pooled analysis of safety data from 12 double-blind, randomized trials.

Results from the DIRECT Program showed that candesartan reduced the incidence of diabetic retinopathy in patients with type 1 diabetes and reduced the regression of retinopathy in those with type 2 diabetes. However, the study did not meet its primary endpoints.

Transition Therapeutics Inc. announced that the first patient has been dosed in a Phase 2 clinical study of gastrin analogue, TT-223.

GI Dynamics announces data demonstrating immediate and sustained reduction in HbA1c in patients with type 2 diabetes using EndoBarrier™ Gastrointestinal Liner. Compelling clinical data highlighted at first World Congress on Interventional Therapies for Type 2 Diabetes show improved glycemic control and weight reduction in uncontrolled diabetics.

For the first time, researchers have identified variations in a single gene that are strongly associated with kidney diseases disproportionately affecting African-Americans. This work was conducted by researchers at the National Institutes of Health (NIH) and by NIH-funded investigators at the Johns Hopkins University.

Obese people with diabetes are just as likely to go undiagnosed as their slimmer peers with the disease, Harvard Medical School researchers report.

A study by researchers from the Joslin Diabetes Center has shown for the first time that more than half of patients with type 2 diabetes who enrolled in a novel short-term weight management program were able to maintain the weight loss they achieved during the program on their own long-term. …

New research reports that Januvia is currently prescribed most often as a third- or later-line of therapy for the treatment of type 2 diabetes.

A large study of Swedish twins indicates that a common genetic cause underlies both low birth weight and the propensity to develop type 2 diabetes.